Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 658 participants.

Also called NCT01368666

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 658 participants (enrolled count) (from the registry)
Sponsor
Corcym S.r.l (from the registry)
Registry
  • NCT NCT01368666
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Belgium, France, Germany, Netherlands, Poland, Switzerland, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01368666. Allocation not applicable; no masking; primary purpose treatment. Start 2010-02-23 (actual); primary completion 2014-10-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
Acronym
CAVALIER
Condition
Aortic Valve Replacement
Intervention (Device)
Perceval S Valve Prosthesis
Lead sponsor
Corcym S.r.l (class: industry)

Record details

Record id
cardio:ct-nct01368666
Content hash
7753e754ded89bc600ddc84a1871983d20bc3bae6aeaf7ac426478a8f888ba40